Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 23801724)

1.

Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study.

Jensen MK, Bartz TM, Djoussé L, Kizer JR, Zieman SJ, Rimm EB, Siscovick DS, Psaty BM, Ix JH, Mukamal KJ.

Diabetes Care. 2013 Oct;36(10):3121-7. doi: 10.2337/dc12-2323. Epub 2013 Jun 25.

2.

Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.

De Silva NM, Freathy RM, Palmer TM, Donnelly LA, Luan J, Gaunt T, Langenberg C, Weedon MN, Shields B, Knight BA, Ward KJ, Sandhu MS, Harbord RM, McCarthy MI, Smith GD, Ebrahim S, Hattersley AT, Wareham N, Lawlor DA, Morris AD, Palmer CN, Frayling TM.

Diabetes. 2011 Mar;60(3):1008-18. doi: 10.2337/db10-1317. Epub 2011 Jan 31.

3.

Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study.

Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH.

Diabetes Care. 2013 Jul;36(7):1994-2000. doi: 10.2337/dc12-1870. Epub 2013 Jan 11.

4.

Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.

Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, Fritsche A, Joost HG, Häring HU, Hubner N, Boeing H, Weikert C.

Circ Cardiovasc Genet. 2009 Dec;2(6):607-13. doi: 10.1161/CIRCGENETICS.109.870410. Epub 2009 Sep 5.

5.

Are AHSG polymorphisms directly associated with coronary atherosclerosis?

Muendlein A, Stark N, Rein P, Saely CH, Geller-Rhomberg S, Geiger K, Vonbank A, Drexel H.

Clin Chim Acta. 2012 Jan 18;413(1-2):287-90. doi: 10.1016/j.cca.2011.10.008. Epub 2011 Oct 15.

PMID:
22024217
6.

Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies.

Talmud PJ, Cooper JA, Gaunt T, Holmes MV, Shah S, Palmen J, Drenos F, Shah T, Kumari M, Kivimaki M, Whittaker J, Lawlor DA, Day IN, Hingorani AD, Casas JP, Humphries SE.

Diabetologia. 2011 Jul;54(7):1710-9. doi: 10.1007/s00125-011-2108-6. Epub 2011 Apr 1.

7.

Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes.

Rees SD, Hydrie MZ, O'Hare JP, Kumar S, Shera AS, Basit A, Barnett AH, Kelly MA.

PLoS One. 2011;6(9):e24710. doi: 10.1371/journal.pone.0024710. Epub 2011 Sep 20.

8.

Multiple genetic variants explain measurable variance in type 2 diabetes-related traits in Pakistanis.

Islam M, Jafar TH, Wood AR, De Silva NM, Caulfield M, Chaturvedi N, Frayling TM.

Diabetologia. 2012 Aug;55(8):2193-204. doi: 10.1007/s00125-012-2560-y. Epub 2012 Apr 28.

PMID:
22538361
9.

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study.

Ix JH, Biggs ML, Mukamal KJ, Kizer JR, Zieman SJ, Siscovick DS, Mozzaffarian D, Jensen MK, Nelson L, Ruderman N, Djousse L.

Circulation. 2012 May 15;125(19):2316-22. doi: 10.1161/CIRCULATIONAHA.111.072751. Epub 2012 Apr 17.

10.

Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.

Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ.

J Clin Endocrinol Metab. 2012 Dec;97(12):4717-23. doi: 10.1210/jc.2012-2414. Epub 2012 Oct 12.

PMID:
23066121
11.

Associations of common genetic variants with age-related changes in fasting and postload glucose: evidence from 18 years of follow-up of the Whitehall II cohort.

Jensen AC, Barker A, Kumari M, Brunner EJ, Kivimäki M, Hingorani AD, Wareham NJ, Tabák AG, Witte DR, Langenberg C.

Diabetes. 2011 May;60(5):1617-23. doi: 10.2337/db10-1393. Epub 2011 Mar 25.

12.

The rs553668 polymorphism of the ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study.

Bo S, Cassader M, Cavallo-Perin P, Durazzo M, Rosato R, Gambino R.

Diabet Med. 2012 Apr;29(4):549-52. doi: 10.1111/j.1464-5491.2011.03522.x.

PMID:
22061269
13.

Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose.

Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, Cavalcanti-Proença C, Efendic S, Ostenson CG, Brismar K, Charpentier G, Gustafsson JA, Froguel P, Dahlman-Wright K, Steffensen KR.

Pharmacogenet Genomics. 2008 Nov;18(11):967-75. doi: 10.1097/FPC.0b013e32831101ef.

PMID:
18854778
14.

AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects.

Andersen G, Burgdorf KS, Sparsø T, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O.

Diabetes. 2008 May;57(5):1427-32. doi: 10.2337/db07-0558. Epub 2008 Mar 3.

15.

Impact of repeated measures and sample selection on genome-wide association studies of fasting glucose.

Rasmussen-Torvik LJ, Alonso A, Li M, Kao W, Köttgen A, Yan Y, Couper D, Boerwinkle E, Bielinski SJ, Pankow JS.

Genet Epidemiol. 2010 Nov;34(7):665-73. doi: 10.1002/gepi.20525.

16.

Fetuin-A and incident diabetes mellitus in older persons.

Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG; Health ABC Study.

JAMA. 2008 Jul 9;300(2):182-8. doi: 10.1001/jama.300.2.182.

17.

Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes.

Yaghootkar H, Lamina C, Scott RA, Dastani Z, Hivert MF, Warren LL, Stancáková A, Buxbaum SG, Lyytikäinen LP, Henneman P, Wu Y, Cheung CY, Pankow JS, Jackson AU, Gustafsson S, Zhao JH, Ballantyne CM, Xie W, Bergman RN, Boehnke M, el Bouazzaoui F, Collins FS, Dunn SH, Dupuis J, Forouhi NG, Gillson C, Hattersley AT, Hong J, Kähönen M, Kuusisto J, Kedenko L, Kronenberg F, Doria A, Assimes TL, Ferrannini E, Hansen T, Hao K, Häring H, Knowles JW, Lindgren CM, Nolan JJ, Paananen J, Pedersen O, Quertermous T, Smith U; GENESIS Consortium; RISC Consortium, Lehtimäki T, Liu CT, Loos RJ, McCarthy MI, Morris AD, Vasan RS, Spector TD, Teslovich TM, Tuomilehto J, van Dijk KW, Viikari JS, Zhu N, Langenberg C, Ingelsson E, Semple RK, Sinaiko AR, Palmer CN, Walker M, Lam KS, Paulweber B, Mohlke KL, van Duijn C, Raitakari OT, Bidulescu A, Wareham NJ, Laakso M, Waterworth DM, Lawlor DA, Meigs JB, Richards JB, Frayling TM.

Diabetes. 2013 Oct;62(10):3589-98. doi: 10.2337/db13-0128. Epub 2013 Jul 8. Review.

18.

Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?

Axelsson J, Wang X, Ketteler M, Qureshi AR, Heimbürger O, Bárány P, Lindholm B, Nordfors L, Stenvinkel P.

Am J Nephrol. 2008;28(4):669-76. doi: 10.1159/000121358. Epub 2008 Mar 13.

PMID:
18337634
19.

Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic β-cell function over 5 years of follow-up.

Andersson EA, Allin KH, Sandholt CH, Borglykke A, Lau CJ, Ribel-Madsen R, Sparsø T, Justesen JM, Harder MN, Jørgensen ME, Jørgensen T, Hansen T, Pedersen O.

Diabetes. 2013 Oct;62(10):3610-7. doi: 10.2337/db13-0362. Epub 2013 Jul 8.

20.

Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.

Wang H, Liu L, Zhao J, Cui G, Chen C, Ding H, Wang DW.

PLoS One. 2013 Jun 28;8(6):e67665. doi: 10.1371/journal.pone.0067665. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk